Evidence map›Paper›PMID 36128418›Full record

ReviewCardiology research2022

Arrhythmogenic Right Ventricular Cardiomyopathy: The Role of Genetics in Diagnosis, Management, and Screening.

Mihir Odak, Steven Douedi, Anton Mararenko, Abbas Alshami, Islam Elkherpitawy, Hani Douedi, Eran Zacks, Brett Sealove

Open access · diamondAbstract readReview
In one paragraph

Review in Cardiology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mihir OdakDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Steven DouediDepartment of Cardiology, Deborah Heart and Lung Center, Browns Mills, NJ 08015, USA.
Anton MararenkoDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Abbas AlshamiDivision of Cardiology, Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Islam ElkherpitawyDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Hani DouediDepartment of Cardiology, Community Medical Center, Toms River, NJ 08753, USA.
Eran ZacksDivision of Cardiology, Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Brett SealoveDivision of Cardiology, Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Jersey Shore University Medical Center · USCommunity Medical Center · USDeborah Heart and Lung Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a predominantly autosomal dominant genetic condition in which fibrous and fatty tissue infiltrate and replace healthy myocardial tissue. This uncommon yet debilitating condition can cause ventricular arrhythmias, cardiac failure, and sudden cardiac death. Management focuses primarily on prevention of syndrome sequelae in order to prevent morbidity and mortality. Genetic testing and screening in affected families, although utilized clinically, has not yet been incorporated in guidelines due to lack of larger studies and data. We aim herein to identify causative gene mutations, present advancements in diagnosis and management, and describe the role of genetic screening and counseling in patients with ARVC. With the advancement of genetic testing and therapy, diseases such as ARVC may become more accurately diagnosed and more effectively managed, ultimately significantly reducing morbidity and mortality.

Indexed as

ArrhythmiaArrhythmogenic right ventricular cardiomyopathyCardiomyopathyGenetics

Identifiers

PMID36128418
PMCPMC9451588
OpenAlexW4291368113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.